MA52795A - Dérivé de carbamoylpyridone polycyclique - Google Patents
Dérivé de carbamoylpyridone polycycliqueInfo
- Publication number
- MA52795A MA52795A MA052795A MA52795A MA52795A MA 52795 A MA52795 A MA 52795A MA 052795 A MA052795 A MA 052795A MA 52795 A MA52795 A MA 52795A MA 52795 A MA52795 A MA 52795A
- Authority
- MA
- Morocco
- Prior art keywords
- polycyclic carbamoylpyridone
- carbamoylpyridone derivative
- derivative
- polycyclic
- carbamoylpyridone
- Prior art date
Links
- OHEKQGOBJIKKIF-AWEZNQCLSA-N (12as)-n-[(4-fluorophenyl)methyl]-7-hydroxy-6,8-dioxo-3,4,12,12a-tetrahydro-2h-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide Chemical class C([C@@H]1OCCCN1C(=O)C1=C(C2=O)O)N1C=C2C(=O)NCC1=CC=C(F)C=C1 OHEKQGOBJIKKIF-AWEZNQCLSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018104156 | 2018-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52795A true MA52795A (fr) | 2021-04-14 |
Family
ID=68698918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052795A MA52795A (fr) | 2018-05-31 | 2019-05-30 | Dérivé de carbamoylpyridone polycyclique |
Country Status (22)
Country | Link |
---|---|
US (2) | US11649236B2 (fr) |
EP (2) | EP4257137A3 (fr) |
JP (2) | JP7328962B2 (fr) |
KR (1) | KR20210015922A (fr) |
CN (2) | CN112513042B (fr) |
AR (1) | AR115455A1 (fr) |
AU (2) | AU2019277548B2 (fr) |
BR (1) | BR112020024077A2 (fr) |
CA (1) | CA3102063A1 (fr) |
CL (1) | CL2020003002A1 (fr) |
CO (1) | CO2020014294A2 (fr) |
CR (2) | CR20230571A (fr) |
DO (1) | DOP2020000221A (fr) |
EA (1) | EA202092921A1 (fr) |
IL (1) | IL279051A (fr) |
MA (1) | MA52795A (fr) |
MX (2) | MX2020012176A (fr) |
PE (1) | PE20210477A1 (fr) |
PH (1) | PH12020552000A1 (fr) |
SG (1) | SG11202011382PA (fr) |
WO (1) | WO2019230858A1 (fr) |
ZA (1) | ZA202007567B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4122537A1 (fr) | 2019-03-22 | 2023-01-25 | Gilead Sciences, Inc. | Composés tricycliques pontés de carbamoylpyridone et leur utilisation pharmaceutique |
US20230059640A1 (en) * | 2019-11-28 | 2023-02-23 | Shionogi & Co., Ltd. | Prophylactic and therapeutic pharmaceutical agent for hiv infectious diseases characterized by comprising combination of integrase inhibitor and anti-hiv agent |
JPWO2021107065A1 (fr) * | 2019-11-28 | 2021-06-03 | ||
US11697652B2 (en) | 2020-02-24 | 2023-07-11 | Gilead Sciences, Inc. | Tetracyclic compounds and uses thereof |
WO2021233302A1 (fr) * | 2020-05-21 | 2021-11-25 | 南京明德新药研发有限公司 | Dérivés cycliques fusionnés et leur utilisation en pharmacie |
BR112023001325A2 (pt) * | 2020-07-27 | 2023-02-14 | Merck Sharp & Dohme Llc | Composto, composição farmacêutica, e, métodos para tratar uma doença causada por um vírus, para inibir a endonuclease dependente de cápsula, para tratar influenza em um mamífero e para prevenir influenza em um mamífero |
WO2022159387A1 (fr) | 2021-01-19 | 2022-07-28 | Gilead Sciences, Inc. | Composés de pyridotriazine substitués et leurs utilisations |
WO2023006087A1 (fr) * | 2021-07-30 | 2023-02-02 | 南京明德新药研发有限公司 | Composé de pyridone macrocyclique et son application |
WO2024061257A1 (fr) * | 2022-09-20 | 2024-03-28 | 吉斯凯(苏州)制药有限公司 | Composé cétone n-hétérocyclique polycyclique et son utilisation |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003267098B2 (en) | 2002-09-11 | 2008-11-20 | Merck & Co., Inc. | Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
EP1578748B1 (fr) | 2002-12-27 | 2010-09-15 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Tetrahydro-4h-pyrido[1,2-a]pyrimidines et composes connexes convenant comme inhibiteurs de l'integrase du vih |
TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
EP1852434B1 (fr) | 2005-02-21 | 2011-07-13 | Shionogi Co., Ltd. | Dérivé de carbamoylpyridone bicyclique ayant une activité d'inhibition de la vih intégrase |
WO2006116764A1 (fr) | 2005-04-28 | 2006-11-02 | Smithkline Beecham Corporation | Derive polycyclique de la carbamoylpyridone a activite inhibitrice sur l'integrase du vih |
CA2626956A1 (fr) | 2005-10-27 | 2007-05-03 | Shionogi & Co., Ltd. | Derive de carbamoylpyridone polycyclique ayant une activite d'inhibition sur l'integrase du vih |
WO2011105590A1 (fr) | 2010-02-26 | 2011-09-01 | 日本たばこ産業株式会社 | Dérivé de 1,3,4,8-tétrahydro-2h-pyrido[1,2-a]pyrazine et son utilisation comme inhibiteur d'intégrase de vih |
JP5766690B2 (ja) | 2010-04-12 | 2015-08-19 | 塩野義製薬株式会社 | インテグラーゼ阻害活性を有するピリドン誘導体 |
US9200009B2 (en) | 2011-10-12 | 2015-12-01 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase inhibitory activity |
WO2014099586A1 (fr) * | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | Dérivés 4-pyridinonetriazines en tant qu'inhibiteurs de l'intégrase du vih |
KR102527797B1 (ko) | 2012-12-21 | 2023-05-03 | 길리애드 사이언시즈, 인코포레이티드 | 폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도 |
US20140221380A1 (en) | 2012-12-27 | 2014-08-07 | Japan Tobacco Inc. | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR |
ME02977B (fr) | 2013-05-17 | 2018-10-20 | Merck Sharp & Dohme | Composés hétérocycliques tricycliques fusionnés utiles en tant qu'inhibiteurs de l'intégrase du vih |
EP3008044B1 (fr) * | 2013-06-13 | 2018-11-21 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques fusionnés utiles en tant qu'inhibiteurs de l'intégrase du vih |
CA2916993C (fr) | 2013-07-12 | 2019-01-15 | Gilead Sciences, Inc. | Composes polycycliques-carbomoylpyridone et leur utilisation pharmaceutique |
NO2865735T3 (fr) | 2013-07-12 | 2018-07-21 | ||
WO2015039348A1 (fr) | 2013-09-23 | 2015-03-26 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tétracycliques utiles comme inhibiteurs de l'intégrase du vih |
EA030695B1 (ru) | 2013-09-27 | 2018-09-28 | Мерк Шарп И Доум Корп. | Замещенные производные хинолизина, которые можно использовать как ингибиторы интегразы вич |
WO2015089847A1 (fr) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Composés à hétérocycles spirocycliques utiles en tant qu'inhibiteurs d'intégrase du vih |
WO2015199167A1 (fr) | 2014-06-25 | 2015-12-30 | 日本たばこ産業株式会社 | PROCÉDÉ POUR PRÉPARER UN DÉRIVÉ SUBSTITUÉ DE SPIROPYRIDO[1,2-a]PYRAZINE ET INTERMÉDIAIRE |
EP3196201B1 (fr) | 2014-08-22 | 2021-04-28 | Shionogi & Co., Ltd. | Dérivé de pyridone polycyclique possédant une activité inhibitrice d'intégrase |
WO2016090545A1 (fr) | 2014-12-09 | 2016-06-16 | Merck Sharp & Dohme Corp. | Composés hétérocycliques spirocycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
EP3229804B1 (fr) | 2014-12-09 | 2020-05-06 | Merck Sharp & Dohme Corp. | Composés hétérocycliques spirocycliques utiles comme inhibiteurs du vih |
TWI695003B (zh) * | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
EP3285582B1 (fr) | 2015-03-26 | 2020-11-11 | Merck Sharp & Dohme Corp. | Dérivés de quinolizine substitués par un phosphate utiles en tant qu'inhibiteurs de l'intégrase du vih |
AU2016244035B2 (en) | 2015-04-02 | 2018-11-01 | Gilead Sciences, Inc. | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
WO2016187788A1 (fr) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques fusionnés utiles pour traiter l'infection au vih |
WO2017087257A1 (fr) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Dérivés de pyridotriazine amido-substitués utiles en tant qu'inhibiteurs de l'intégrase du vih |
US10624912B2 (en) | 2015-11-17 | 2020-04-21 | Merck Sharp & Dohme Corp. | Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors |
WO2017106071A1 (fr) | 2015-12-15 | 2017-06-22 | Merck Sharp & Dohme Corp. | Dérivés de quinolizine spirocycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
WO2017113288A1 (fr) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques condensés utiles en tant qu'inhibiteurs de l'intégrase du vih |
JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
JP2020500866A (ja) | 2016-12-02 | 2020-01-16 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Hivインテグラーゼ阻害剤として有用な三環式複素環化合物 |
WO2019160783A1 (fr) | 2018-02-15 | 2019-08-22 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
WO2019209667A1 (fr) | 2018-04-27 | 2019-10-31 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
CN110526930B (zh) | 2018-05-23 | 2022-06-03 | 莫云芬 | 抗hiv病毒的含硫多环-羟基吡啶酮甲酰胺类似物及其应用 |
WO2019230857A1 (fr) | 2018-05-31 | 2019-12-05 | 塩野義製薬株式会社 | Dérivé de pyridone polycyclique |
WO2019236396A1 (fr) | 2018-06-05 | 2019-12-12 | Merck Sharp & Dohme Corp. | Composés hétérocycliques tricycliques utiles en tant qu'inhibiteurs de l'intégrase du vih |
CN108957755B (zh) | 2018-07-27 | 2021-04-30 | 京东方科技集团股份有限公司 | 一种显示组件及其控制方法、平视显示器及汽车 |
EP4122537A1 (fr) | 2019-03-22 | 2023-01-25 | Gilead Sciences, Inc. | Composés tricycliques pontés de carbamoylpyridone et leur utilisation pharmaceutique |
-
2019
- 2019-05-30 CR CR20230571A patent/CR20230571A/es unknown
- 2019-05-30 WO PCT/JP2019/021446 patent/WO2019230858A1/fr active Application Filing
- 2019-05-30 EP EP23192706.2A patent/EP4257137A3/fr active Pending
- 2019-05-30 CN CN201980050399.5A patent/CN112513042B/zh active Active
- 2019-05-30 BR BR112020024077-0A patent/BR112020024077A2/pt unknown
- 2019-05-30 MX MX2020012176A patent/MX2020012176A/es unknown
- 2019-05-30 CR CR20200644A patent/CR20200644A/es unknown
- 2019-05-30 PE PE2020001863A patent/PE20210477A1/es unknown
- 2019-05-30 US US17/058,251 patent/US11649236B2/en active Active
- 2019-05-30 CN CN202311258763.1A patent/CN117327072A/zh active Pending
- 2019-05-30 MA MA052795A patent/MA52795A/fr unknown
- 2019-05-30 CA CA3102063A patent/CA3102063A1/fr active Pending
- 2019-05-30 EA EA202092921A patent/EA202092921A1/ru unknown
- 2019-05-30 AU AU2019277548A patent/AU2019277548B2/en active Active
- 2019-05-30 EP EP19810498.6A patent/EP3805220A4/fr active Pending
- 2019-05-30 JP JP2020522577A patent/JP7328962B2/ja active Active
- 2019-05-30 SG SG11202011382PA patent/SG11202011382PA/en unknown
- 2019-05-30 AR ARP190101467A patent/AR115455A1/es unknown
- 2019-05-30 KR KR1020207037580A patent/KR20210015922A/ko not_active Application Discontinuation
-
2020
- 2020-11-13 MX MX2023010377A patent/MX2023010377A/es unknown
- 2020-11-18 CL CL2020003002A patent/CL2020003002A1/es unknown
- 2020-11-18 CO CONC2020/0014294A patent/CO2020014294A2/es unknown
- 2020-11-20 PH PH12020552000A patent/PH12020552000A1/en unknown
- 2020-11-27 DO DO2020000221A patent/DOP2020000221A/es unknown
- 2020-11-29 IL IL279051A patent/IL279051A/en unknown
- 2020-12-04 ZA ZA2020/07567A patent/ZA202007567B/en unknown
-
2023
- 2023-03-22 US US18/124,827 patent/US20230227454A1/en active Pending
- 2023-08-03 JP JP2023127333A patent/JP2023145723A/ja active Pending
-
2024
- 2024-02-08 AU AU2024200783A patent/AU2024200783A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52795A (fr) | Dérivé de carbamoylpyridone polycyclique | |
DK3810587T3 (da) | Substituerede alkoxypyridinylindolsulfonamider | |
MA52802A (fr) | Dérivé de pyridone polycyclique | |
DK3768669T3 (da) | Piperazinazaspiroderivater | |
DK3823970T3 (da) | Yderligere substituerede triazoloquinoxalinderivater | |
DK3823971T3 (da) | Substituerede triazol-quinoxalin-derivater | |
DK3796975T3 (da) | Sulfonylaminobenzamidderivater | |
DK3894410T3 (da) | Substituerede xanthinderivater | |
DK3770162T3 (da) | Dihydrochromenderivater | |
DK3752258T3 (da) | Trampolin | |
DK3587968T3 (da) | Fluidsystem | |
MA49925A (fr) | Claie | |
DE112019000442A5 (de) | Ringtilgereinrichtung | |
NO20181678A1 (no) | Rissanviser | |
JP1628555S (ja) | たい焼 | |
JP1628556S (ja) | たい焼 | |
ES1218724Y (es) | Terrario | |
ES1224156Y (es) | Ecobolsera | |
UA38411S (uk) | Термокухоль | |
UA38582S (uk) | Термокухоль | |
UA38585S (uk) | Електролобзик | |
UA38598S (uk) | Пневмофарбопульт | |
UA38602S (uk) | Термокухоль | |
UA38581S (uk) | Термокухоль | |
UA38606S (uk) | Електролобзик |